The first part of the title is a nod to a book by the same name. The book by Rosemary Gibson and Janardan Prasad Singh, “China Rx”, discusses the consequences of China’s dominance in the production of the world’s basic drugs and how it occurred. The “More” discusses the global supply train and how the Coronavirus is highlighting its downside. Continue reading
One of the main objectives for the Business Management Standard BMS75k was to address the need to establish and verify Business Decisions with the same degree of control that we afford products and service quality.
In dealing with the individual clauses and subjects of the management standards, the subject of risk has to be considered as this is significant in ISO9001:2015: and even more so for the Business Management Standard BMS75k which commends the use of planning and preparation in respect of risk management and control. Continue reading
Most executives believe that no one can tell them how to do better in order to achieve more of the goal of the organization. This is a very comfortable thought, and it could be logically based on the claim that the one who achieved so nicely so far is able to continue to do even more. Continue reading
We are born. We grow up to become adults. We reach a peak of functionality and capability. Then we start a long slow slide into weakness, sickness, and ultimately to death by “old age.” Old Age is effectively synonymous with chronic diseases and disability. Those chronic diseases are all too familiar to people who have entered their “golden years” or who know someone who has. Continue reading
You have already made an important risk management decision this year. You have already actively or passively determined what you are doing about the novel coronavirus COVID-19(COVID19) pandemic.
Regardless of the decision you have made to date, the rapidly evolving COVID19 pandemic requires continuous assessment and adjustment of your risk management decisions and mitigations. Continue reading